LongBio Pharma, a portfolio company of Qiming Venture Partners and a leading innovative drug developer for allergic and ...
Australia-based Gelteq has announced the establishment of a new Gelteq Centre of Excellence in Guangdong Province, China...
Shanghai Henlius Biotech and Organon have received European Commission marketing authorisation for POHERDY, a pertuzumab...
China-based Everest Medicines has entered into an exclusive licensing and collaboration agreement with US-based Travere ...
China-based Haisco Pharmaceutical Group has announced a licensing and research collaboration with American firm Eli Lill...
Biond Biologics, a private clinical-stage biotechnology company developing first-in-class immunotherapies for cance...
China-based Innovent Biologics and American firm Pfizer Inc. have entered into a strategic global licensing and collabor...
Samsung Epis Holdings Co., an investment holding company dedicated to innovation in biopharmaceuticals and biotechnology...
Insilico Medicine, a Hong Kong-headquartered clinical-stage generative artificial intelligence (AI)-driven biotechnology...
Cornerstone Robotics (CSR), a leading global innovator in surgical robotics based in Hong Kong, China, has announced tha...
On May 15, 2026, China’s National Medical Products Administration (“NMPA”) issued the Implementat...
Accro Bioscience Inc., a China-based clinical-stage biotechnology startup pioneering the development of novel thera...
The Hong Kong Hub of Obstetric and Paediatric Excellence (HOPE) at The Chinese University of Hong Kong (CUHK) and Hangzh...
Shanghai Fosun Pharmaceutical (Group) and South Korea-based AriBio Co., a biopharmaceutical company focused on neurodege...
METiS TechBio, a tech-bio company focused on AI-powered nanodelivery innovation, has successfully listed on the Hong Kon...
Reporting on ground from API China 2026, BioSpectrum Asia observed growing industry attention around the Middle East and...
Reporting on ground from API China 2026, BioSpectrum Asia observed strong international interest aro...
Reporting on ground from API China 2026, BioSpectrum Asia observed a strong strategic focus on the f...
Australia-based Nexsen has entered into a binding term sheet with GHK Hospital, a subsidiary of IHH Healthcare Berhad, e...
China’s pharmaceutical industry is rapidly advancing towards intelligent manufacturing ecosystems, with smart phar...
The opening session of the 2026 Pharmaceutical Innovation And Compliance Development Forum,...
API China 2026 was officially inaugurated today alongside co located industry exhibitions including PharmChina 2026, NHN...
GSK plc has entered into an exclusive strategic collaboration with Sino Biopharmaceutical (SBP Group), through its subsi...
Singapore's Health Sciences Authority (HSA) and China's National Medical Products Administration (NMPA) have signed a Me...
China-based Hengrui Pharma and Bristol Myers Squibb (BMS) have announced the companies have entered into globa...
